Mechanisms involved in the antinociception caused by compound MV8612 isolated from Mandevilla velutina in mice

Brain Research

Volumn 961, Issue 2, 2003, Pages 269-276

  Santos, Adair R S ^a   Trentin, Ana Paula ^a   Ferreira, Juliano ^a   Yunes, Rosendo A ^a   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antinociception; Bradykinin; Gi protein; Glutamate; K+ channel; Mandevilla velutina; MV8612

Indexed keywords

APAMIN; BRADYKININ; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CAPSAICIN; CHARYBDOTOXIN; FORMALDEHYDE; GLIBENCLAMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MV 8612; PERTUSSIS TOXIN; POTASSIUM ION; PREGNANE DERIVATIVE; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CALCIUM CONDUCTANCE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NONHUMAN; PAIN; PLANT; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; APAMIN; BRADYKININ; CAPSAICIN; CHARYBDOTOXIN; FORMALDEHYDE; GLYBURIDE; GLYCOSIDES; GTP-BINDING PROTEINS; HEAT; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; MORPHINE; PAIN; PERTUSSIS TOXIN; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; STEROIDS; TETRAETHYLAMMONIUM;

EID: 0037473964     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03968-9     Document Type: Article

References (45)

1. Aronsen J.K. Potassium channels in nervous tissue. Biochem. Pharmacol. 43:1992;11-14.
2. Beirith A., Santos A.R.S., Rodrigues A.L.S., Creczynski-Pasa T.B., Calixto J.B. Spinal and supraspinal antinociceptive action of dipyrone on formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur. J. Pharmacol. 345:1998;233-245.
3. 9)-BK-induced contraction of isolated rabbit vessels. Br. J. Pharmacol. 85:1986;937-941.
4. Calixto J.B., Yunes R.A. Blockade of kinin-induced responses of the isolated guinea-pig urinary bladder by the extract of Mandevilla velutina. Gen. Pharmacol. 21:1990;285-290.
5. Calixto J.B., Nicolau M., Yunes R.A. The selective antagonism of bradykinin action on isolated rat uterus by crude Mandevilla velutina extract. Br. J. Pharmacol. 85:1985;729-731.
6. Calixto J.B., Cabrini D.A., Ferreira J., Campos M.M. Inflammatory pain: kinins and antagonists. Curr. Opin. Anaesthesiol. 14:2001;519-526.
7. Calixto J.B., Cabrini D.A., Ferreira J., Campos M.M. Kinins in pain and inflammation. Pain. 87:2000;1-5.
8. Calixto J.B., Nicolau M., Trebien H.A., Henriques M.G.O., Weg V.C., Cordeiro R.S.B., Yunes R.A. Antiedematogenic actions of a hydroalcoholic crude water-alcohol extract of Mandevilla velutina. Braz. J. Med. Biol. Res. 19:1986;575A.
9. Calixto J.B., Nicolau M., Pizzolatti M., Yunes R.A. Kinin antagonistic activity of compounds from Mandevilla velutina in the isolated rat uterus. Br. J. Pharmacol. 91:1987;199-204.
10. Calixto J.B., Nicolau M., Yunes R.A. Antagonistic effect of Mandevilla velutina extract on kinin-induced contractions of guinea-pig and cat ileum longitudinal smooth muscle. Gen. Pharmacol. 19:1988;595-599.
11. Calixto J.B., Pizzolatti M.G., Yunes R.A. The competitive antagonist effect of compounds from Mandevilla velutina on kinin-induced contractions of rat uterus and guinea-pig ileum in vitro. Br. J. Pharmacol. 94:1988;1133-1142.
12. Calixto J.B., Strobel G.H., Yunes R.A. Blockade of the bradykinin-evoked diphasic response of isolated rat duodenum by the crude extract of and compounds obtained from Mandevilla velutina. Braz. J. Med. Biol. Res. 12:1988;1015-1018.
13. Calixto J.B., Zanini J.C. Jr., Cruz A.B., Yunes R.A., Medeiros Y.S. Extract and compounds obtained from Mandevilla velutina inhibit arachidonic acid-induced ear oedema in mice, but not rat stomach contraction. Prostaglandins. 41:1991;515-526.
14. Calixto J.B., Yunes R.A., Rae G.A., Medeiros Y.S. Non-peptide bradykinin antagonism. Burch R.M. Bradykinin Antagonists: Basic and Clinical Research. 1991;97-129 Marcel Dekker, New York.
15. Chapman V., Dickenson A.H. The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur. J. Pharmacol. 219:1992;427-433.
16. 2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol. 110:1993;193-198.
17. Corrêa C.R., Kyle D.J., Chakravarty S., Calixto J.B. Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice. Br. J. Pharmacol. 117:1996;552-558.
18. 2 receptor antagonist. Eur. J. Pharmacol. 316:1996;277-286.
19. Dray A., Perkins M.N. Kinins and pain. Farmer S.G. The Kinin System. 1997;157-172 Academic Press, San Diego, CA.
20. 2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level, Neuropharmacology (2002) (in press).
21. Ferreira J., Santos A.R.S., Calixto J.B. The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice. Neuropharmacology. 38:1999;835-842.
22. 2 receptor knockout mice. Neuropharmacology. 41:2001;1006-1012.
23. Gammon C.M., Lyons S.A., Morell P. Modulation of neuropeptides of bradykinin-stimulated second messenger release in dorsal root ganglion neurons. Brain Res. 518:1990;159-165.
24. Gimemez-Gallego G., Navia M.A., Reuben J.P., Katz G.M., Kaczorowski G.J., Garcia M.L. Purification, sequence and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc. Natl. Acad. Sci. USA. 85:1988;3329-3333.
25. Haley J.E., Dickenson A.H., Schachter M. Electrophysiological evidence for a role of bradykinin in chemical nociception in the rat. Neurosci. Lett. 97:1989;198-202.
26. Henriques M.G.M.O., Fernandes P.D., Weg V.B., Yunes R.A., Cordeiro R.S.B., Calixto J.B. Inhibition of rat paw oedema and pleurisy by the extract from Mandevilla velutina. Agents Actions. 33:1991;272-278.
27. Hernandez A., Soto-Moyano R., Mestre C., Eschalier A., Pelissier I., Paeile C., Contreras E. Intrathecal pertussis toxin but not cyclic AMP blocks kappa opioid-induced antinociception in rat. Int. J. Neurosci. 81:1995;193-197.
28. Hylden J.K.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
29. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice: some methodological refinements. J. Pharmacol. Methods. 16:1986;355-357.
30. Mendes G.L., Santos A.R.S., Malheiros A., Cechinel Filho V., Yunes R.A., Calixto J.B. Assessment of mechanisms involved in antinociception caused by sesquiterpene polygodial. J. Pharmacol. Exp. Ther. 292:2000;164-172.
31. Naruse K., McGehee D.S., Oxford G.S. Differential responses of Ca-activated K channels to bradykinin in sensory neurons and F-11 cells. Am. J. Physiol. 262:1992;C453-C460.
32. 2 and phospholipase C. Eur. J. Pharmacol. 243:1993;213-219.
33. Pertwee R.G. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6:1999;635-664.
34. 1 receptors. Proc. Natl. Acad. Sci. USA. 97:2000;8140-8145.
35. Premkumar L.S., Ahern G.P. Induction of vanilloid receptor channel activity by protein kinase C. Nature. 408:2000;985-990.
36. Santos A.R.S., Calixto J.B. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice. Neuropeptides. 31:1997;381-389.
37. + channels and Gi/o protein in the antinociceptive action of the gallic acid ethyl ester. Eur. J. Pharmacol. 379:1999;7-17.
38. Schultz J.J., Gross G.J. Opioids and cardioprotection. Pharmacol. Ther. 89:2001;123-137.
39. Shah S., Duttaroy A., Davis T., Yoburn B.C. Spinal and supraspinal effects of pertussis toxin on opioid analgesia. Pharmacol. Biochem. Behav. 49:1994;773-776.
40. Shah S., Breivogel C., Selly D., Munirathinam G., Childers S., Yoburn C. Time-dependent effects of in vivo pertussis toxin on morphine analgesia and G-proteins in mice. Pharmacol. Biochem. Behav. 56:1997;465-469.
41. Strong P.N. Potassium channel toxins. Pharmacol. Ther. 46:1990;137-162.
42. Vaz Z.R., Cechinel-Filho V., Yunes R.A., Calixto J.B. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice. J. Pharmacol. Exp. Ther. 278:1996;304-312.
43. Welch S.P., Dunlow L.D. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action? J. Pharmacol. Exp. Ther. 267:1993;390-399.
44. 9-THC-induced antinociception. J. Pharmacol. Exp. Ther. 273:1995;1235-1244.
45. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.